Health Care Medicare premium increase from Alzheimer’s drug to be lowered next year Health Care / 3 years ago by Joseph Choi 05/27/22 4:30 PM ET
Policy Biogen CEO stepping down after Medicare decision on Alzheimer’s drug Policy / 3 years ago by Joseph Choi 05/03/22 10:03 AM ET
Health Care Medicare finalizes decision to limit coverage of controversial Alzheimer’s drug to those in clinical trial Health Care / 3 years ago by Peter Sullivan 04/07/22 5:10 PM ET
Health Care Biogen halves price of controversial Alzheimer’s drug Health Care / 3 years ago by Nathaniel Weixel 12/20/21 10:48 AM ET
Health Care Sanders urges Biden to delay Medicare premium hike linked to Alzheimer’s drug Health Care / 3 years ago by Nathaniel Weixel 12/03/21 4:40 PM ET
Health Care Medicare premiums to jump in part due to pricey Alzheimer’s drug Health Care / 3 years ago by Peter Sullivan 11/12/21 6:23 PM ET
Health Care House panels press Biogen for documents on controversial Alzheimer’s drug Health Care / 3 years ago by Peter Sullivan 07/12/21 5:11 PM ET
Health Care Biogen CEO says $56K a year for new Alzheimer’s drug is a ‘fair’ price Health Care / 4 years ago by Joseph Choi 06/07/21 4:35 PM ET
